Target intelligence / Profile preview

null

Target
null
Molecular classification
Other
01

Overview

Hepatocyte regeneration refers to the process by which hepatocytes, the main functional cells of the liver, proliferate to restore liver mass and function following injury or partial hepatectomy[1][3][4]. This regenerative response is regulated by a complex interplay of cellular and molecular mechanisms involving growth factors (such as hepatocyte growth factor (HGF) and transforming growth factor alpha (TGF-α)), cytokines (such as interleukin-6 and tumor necrosis factor alpha), and multiple intracellular signaling pathways including IL-6/STAT3, PI3-K/PDK1/Akt, Wnt/β-catenin, Hippo/YAP, and Notch[1][2][3][4]. The process occurs in three main stages: initiation (priming), proliferation, and termination. Hepatocyte regeneration is critical for liver health, as it allows recovery from a wide range of insults, but it is not itself a single druggable molecular entity or biomarker[1][3][4]. Summary: "Hepatocyte regeneration" describes a cellular repair process and is not a canonical molecular drug target; instead, it encompasses numerous signaling pathways and cell types essential for liver recovery and repair[1][2][3][4].

Other names
Hepatocyte proliferationLiver regenerationCompensatory hepatocyte proliferationHepatic regeneration
02

Mechanism of action

null

03

Biological functions

Cell proliferationTissue repairOrgan regenerationCell differentiation
04

Disease associations

Liver diseaseCancerInfectionOther (acute and chronic liver injury)

Beyond the preview

Go deeper on null.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on null.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call